Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rijssen, T.J. van"'
Autor:
Feenstra, H.M.A., Hahn, L.C., Rijssen, T.J. van, Tsonaka, R., Breukink, M.B., Keunen, J.E.E., Peters, P.J.H., Dijkman, G., Souied, E.H., MacLaren, R.E., Querques, G., Downes, S.M., Fauser, S., Hoyng, C.B., Dijk, E.H.C. van, Boon, C.J.F.
Publikováno v:
Retina-The Journal of Retinal and Vitreous Diseases, 42, 4, pp. 721-729
Retina (Philadelphia, Pa.), 42(4), 721-729. Lippincott Williams and Wilkins
RETINA: The Journal of Retinal and Vitreous Diseases, 42(4), 721-729. LIPPINCOTT WILLIAMS & WILKINS
Retina-The Journal of Retinal and Vitreous Diseases, 42, 721-729
Retina (Philadelphia, Pa.), 42(4), 721-729. Lippincott Williams and Wilkins
RETINA: The Journal of Retinal and Vitreous Diseases, 42(4), 721-729. LIPPINCOTT WILLIAMS & WILKINS
Retina-The Journal of Retinal and Vitreous Diseases, 42, 721-729
Purpose: Comparing the effect of half-dose photodynamic therapy and high-density subthreshold micropulse laser treatment on retinal pigment epithelial detachments (PEDs) in chronic central serous chorioretinopathy. Methods: This study included data f
Autor:
Feenstra, H.M.A., Dijk, E.H.C. van, Rijssen, T.J. van, Tsonaka, R., Diederen, R.M.H., Schlingemann, R.O., Hoyng, C.B., Boon, C.J.F.
Publikováno v:
Ophthalmology Retina, 6(10), 930-938. ELSEVIER INC
Feenstra, H M A, van Dijk, E H C, van Rijssen, T J, Tsonaka, R, Diederen, R M H, Schlingemann, R O, Hoyng, C B & Boon, C J F 2022, ' Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients ', Ophthalmology Retina, vol. 6, no. 10, pp. 930-938 . https://doi.org/10.1016/j.oret.2022.04.014
Ophthalmology Retina, 6(10), 930-938. Elsevier Inc.
Ophthalmology Retina, 6, 930-938
Ophthalmology Retina, 6, 10, pp. 930-938
Feenstra, H M A, van Dijk, E H C, van Rijssen, T J, Tsonaka, R, Diederen, R M H, Schlingemann, R O, Hoyng, C B & Boon, C J F 2022, ' Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients ', Ophthalmology Retina, vol. 6, no. 10, pp. 930-938 . https://doi.org/10.1016/j.oret.2022.04.014
Ophthalmology Retina, 6(10), 930-938. Elsevier Inc.
Ophthalmology Retina, 6, 930-938
Ophthalmology Retina, 6, 10, pp. 930-938
Purpose: To compare the efficacy and safety of crossover treatment to half-dose photodynamic therapy (PDT) and eplerenone treatment after the failure of primary treatment in patients with chronic central serous chorioretinopathy (cCSC). Design: Multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76feb7caf99e84b506423c7fb04877e0
http://hdl.handle.net/1887/3485621
http://hdl.handle.net/1887/3485621
Autor:
Rijssen, T.J. van
Publikováno v:
None
This thesis involves the eye disease central serous chorioretinopathy. This disease is characterized by an accumulation of subretinal fluid, which can lead to a reduction in vision, changes in contrast vision and sometimes distortions in the visual f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4c1c689e8cb3b89e5789728737d04cfb
https://hdl.handle.net/1887/3304794
https://hdl.handle.net/1887/3304794
Autor:
Feenstra, H.M.A., Dijk, E.H.C. van, Rijssen, T.J. van, Tsonaka, R., Diederen, R.M.H., Hoyng, C.B., Schlingemann, R.O., Boon, C.J.F.
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. Springer Verlag
Feenstra, H M A, van Dijk, E H C, van Rijssen, T J, Tsonaka, R, Diederen, R M H, Hoyng, C B, Schlingemann, R O & Boon, C J F 2022, ' Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment : SPECTRA trial report No. 3 ', Graefe's Archive for Clinical and Experimental Ophthalmology . https://doi.org/10.1007/s00417-022-05836-x
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 659-668
Graefe s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Springer Verlag
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 3, pp. 659-668
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 659-668. SPRINGER
Feenstra, H M A, van Dijk, E H C, van Rijssen, T J, Tsonaka, R, Diederen, R M H, Hoyng, C B, Schlingemann, R O & Boon, C J F 2022, ' Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment : SPECTRA trial report No. 3 ', Graefe's Archive for Clinical and Experimental Ophthalmology . https://doi.org/10.1007/s00417-022-05836-x
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 659-668
Graefe s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Springer Verlag
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 3, pp. 659-668
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 659-668. SPRINGER
Purpose Comparing anatomic and functional efficacy and safety of primary treatment with either half-dose photodynamic therapy (PDT) or oral eplerenone, or crossover treatment in chronic central serous chorioretinopathy patients. Methods After the SPE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d424502f66210a70eee143b0d7accc0
https://research.vumc.nl/en/publications/7995d6a8-fd1c-4b1e-9681-6a10b99477f4
https://research.vumc.nl/en/publications/7995d6a8-fd1c-4b1e-9681-6a10b99477f4
Autor:
Mohabati, D., Dijk, E.H.C. van, Rijssen, T.J. van, Jong, E.K. de, Breukink, M.B., Martinez-Ciriano, J.P., Dijkman, G., Hoyng, C.B., Fauser, S., Yzer, S., Boon, C.J.F.
Publikováno v:
Acta Ophthalmologica, 95, 21-21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ab30a1d14917afd080840143308d2876
https://hdl.handle.net/1887/116524
https://hdl.handle.net/1887/116524